Benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) or benign prostatic enlargement (BPE) is an extremely common condition in elderly men and is a major cause of bladder outflow obstruction. 

The term benign prostatic hypertrophy was formerly used for this condition, but since there is actually an increase in the number of epithelial and stromal cells in the periurethral area of the prostate, not an enlargement of cells, the more accurate term is hyperplasia.

Although the term prostatomegaly is often used interchangeably with BPH, strictly speaking prostatomegaly may refer to any cause of prostatic enlargement. 

By the age of 60, 50% of men have BPH, and by 90 years of age the prevalence has increased to 90%. As such it is often thought of essentially as a 'normal' part of aging 1.

Although a degree of prostatomegaly may be completely asymptomatic, the most common presentation is with lower urinary tract symptoms (LUTS) including 1-4

  • poor stream despite straining
  • hesitancy, frequency and incomplete emptying of the bladder
  • nocturia

An enlarged prostate may also be incidentally found on imaging of the pelvis or on digital rectal exam. 

The international prostate symptom score (IPSS) is an 8 question (7 symptom questions + 1 quality of life question) scoring system used in assessing clinical severity, tracking symptoms and aiding management in benign prostatic hyperplasia.

Benign prostatic hyperplasia is due to a combination of stromal and glandular hyperplasia, predominantly of the transition zone (as opposed to prostate cancer which typically originates in the peripheral zone).

Androgens (DHT and testosterone) are necessary for the development of BPH, but are not the direct cause for the hyperplasia.

  • increasing age
  • family history
  • race: blacks > whites > asians
  • cardiovascular disease
  • use of beta-blockers
  • metabolic syndrome: diabetes, hypertension, obesity 8

Ultrasound has become the standard first line investigation after the urologist's finger.

  • there is an increase in volume of the prostate with a calculated volume exceeding 30 mL (width x height x length x 0.52)
  • the central gland is enlarged, and is hypoechoic or of mixed echogenicity
  • calcification may be seen both within the enlarged gland as well as in the pseudocapsule (representing compressed peripheral zone)
  • post-micturition residual volume is typically elevated
  • associated bladder wall hypertrophy and trabeculation due to chronically elevated filling pressures

On IVP, the bladder floor can be elevated and the distal ureters lifted medially (J-shaped ureters or fishhook ureters). Chronic bladder outlet obstruction can lead to detrusor hypertrophy, trabeculation and formation of bladder diverticula.

Not typically used to assess the prostate, BPH is more frequently an incidental finding. Extension above the symphysis pubis was used as a marker on axial imaging, however now that volume acquisition and coronal reformats are standard, the same criteria as on US can be used (>30 mL).

  • enlarged transition zone
  • heterogeneous signal with an intact low signal pseudocapsule in the periphery

Medical management for early disease typically commences with an alpha blocker such as tamsulosin given in combination with a 5-alpha reductase inhibitor such as dutasteride. 

Surgical management for symptomatic patients is typically with a transurethral resection of the prostate (TURP), and careful patient selection is important given the high prevalence of both BPH and lower urinary tract symptoms (LUTS) in this population. Intermittent self catheterization is an option for those unsuitable for surgery. 

Prostatic arterial embolization (PAE)  is an emerging minimally invasive procedure which has been shown to have similar efficacy to traditional surgical techniques, with a lower risk of major adverse events such as hemorrhage, urinary tract infection and sexual dysfunction 9

Urodynamic studies and prostate size estimation are often used to guide therapy, although prostate size in isolation is a poor predictor of symptom severity 4.

Complications of untreated benign prostatic hyperplasia include 4:

Share article

Article information

rID: 980
System: Urogenital
Synonyms or Alternate Spellings:
  • Benign prostatic hypertrophy
  • Benign prostatic hypertrophy (BPH)
  • BPH
  • Benign prostatic enlargement
  • Benign enlargement of the prostate
  • BPE

Support Radiopaedia and see fewer ads

Cases and figures

  • Case 1
    Drag here to reorder.
  • Case 2
    Drag here to reorder.
  • Case 3: showing a fishhook ureter
    Drag here to reorder.
  • Case 4
    Drag here to reorder.
  • Case 5
    Drag here to reorder.
  • Case 6
    Drag here to reorder.
  • Case 7
    Drag here to reorder.
  • Case 8
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.